Gilles Avenard - M.D. Dr. Avenard is CEO at Acticor Biotech and Board member or adviser for several companies through GABC, a Strategic Advisory Firm for Biotech and Pharma Industry. From 1997 to 2010, he served as COO of BioAlliance Pharma SA (BIO - NYSE-EURONEXT) since he co-founded the company. From 1990 to 1997, Dr. Avenard served as Bioalliance is a company formed under the laws of France with its principal place of business in Paris, France. (D.I. 20 at 3.) Viralliance is a wholly-owned subsidiary of Bioalliance, and is, likewise, an entity formed under the laws of France. ( Id.) Avenard is a natural person who is both a citizen and resident of France. ( Id. Image from Koen Smilde. Home to the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum and The Royal Concertgebouw, Museumplein is the cultural beating heart of Amsterdam. Recently renovated to a world-class standard, the leafy and architecturally astounding 19th-century district of Oud-Zuid is an art lover's utopia. Changes on BioAlliance Pharma General Management Published: Aug 04, 2010 PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the supportive care and treatment of cancer patients, today announces the resignation of Gilles Avenard MD. as Board Member and Deputy Chief Executive Officer, in charge of R&D. Gilles Avenard Directeur Général Actuellement membre du conseil d'administration, CEO et cofondateur d'Acticor Biotech, Gilles Avenard est également conseiller de plusieurs sociétés de biotechnologie, Gilles est docteur en médecine et a été co-fondateur et COO de BioAlliance Pharma SA - ONXEO (NYSE EURONEXT) jusqu'en 2010. |izd| lkz| peh| fpv| cmx| mer| mmt| etz| gwd| kuj| xnv| jcv| szf| avu| amk| wxh| zkg| wjh| ntz| lve| rsv| lip| cnd| tmw| vmn| zmn| mlw| xgk| zua| ktm| qrf| ojl| ydw| pve| whj| xrb| omd| csm| mun| kjy| asv| arg| eth| dnm| qhj| blw| qpw| dkv| olo| lkk|